Civeo (CVEO) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Q2 2026 revenues rose 11% year-over-year to $180 million, driven by integrated services growth in Australia and Canada, the Qantac Acquisition, and favorable currency movements.
Net loss improved to $2.5 million ($0.23 per diluted share), down from $3.3 million in Q2 2025, reflecting higher revenues and lower depreciation.
Adjusted EBITDA was $23.8 million, slightly down from $25 million in Q2 2025, mainly due to start-up costs and inflation.
Issued $115 million of 4.50% convertible senior notes due 2031 post-quarter, enhancing financial flexibility and enabling significant share repurchases.
Repurchased 660,297 shares (~$22.3 million) post-quarter, completing a 20% buyback and commencing a new 10% authorization.
Financial highlights
Q2 2026 revenues were $180 million, up from $162.7 million in Q2 2025.
Net loss was $2.5 million ($0.23 per diluted share), improving from a $3.3 million loss ($0.25 per share) year-over-year.
Adjusted EBITDA was $23.8 million, down from $25 million in Q2 2025.
Operating cash flow improved to $11.6 million from negative $2.3 million year-over-year.
Six-month revenue was $352.7 million (up 15% year-over-year), with a six-month net loss of $6.3 million, improved from $13.2 million loss in prior year.
Outlook and guidance
Full-year 2026 revenue guidance remains $675–$700 million; adjusted EBITDA guidance is $85–$90 million.
Capital expenditure guidance for 2026 is unchanged at $25–$30 million.
Canada projected to see ~20% revenue growth in H2 2026 versus H2 2025, driven by integrated services and turnaround activity.
Australia expected to face continued cost pressures through year-end, with improvement anticipated in 2027.
Management continues to monitor commodity prices, inflation, and customer capital spending for future adjustments.
Latest events from Civeo
- All shareholder proposals passed, including director elections and equity plan amendment.CVEO
AGM 202627 May 2026 - Q1 2026 revenue up 20%, EBITDA up 78%, net loss narrowed, and share repurchases continued.CVEO
Q1 20261 May 2026 - Strong Q4 results, record Australian revenues, and robust buybacks set up a positive 2026 outlook.CVEO
Q4 202528 Apr 2026 - 2026 meeting covers director elections, pay, equity plan, auditor ratification, and ESG progress.CVEO
Proxy filing13 Apr 2026 - Q2 net income doubled to $8.2M as Australian growth offset Canadian declines; guidance steady.CVEO
Q2 20242 Feb 2026 - Australian growth offsets Canadian declines as Q3 net loss posted, major contract secured.CVEO
Q3 202417 Jan 2026 - Australian growth and contract wins offset Canadian restructuring; 2025 outlook cautious.CVEO
Q4 202424 Dec 2025 - 2025 meeting covers director elections, executive pay, auditor ratification, and ESG progress.CVEO
Proxy Filing1 Dec 2025 - 2025 guidance lowered as share repurchases prioritized amid Canadian and currency headwinds.CVEO
Q1 202528 Nov 2025